Po-Sen Huang1, Zhih-Cherng Chen1,2, Kuo-Ting Tang1, Wei-Ting Chang1,3. 1. Division of Cardiology, Department of Internal Medicine, Chi-Mei Medical Center. 2. Department of Pharmacy, Chia Nan University of Pharmacy and Science. 3. Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan.
Abstract
BACKGROUND: Percutaneous interventions help patients with various cardiovascular diseases, however radiation exposure is a safety concern for both patients and health care providers. We previously reported that dose area product (DAP) is apparently different in central body and upper-limb areas during percutaneous transluminal angioplasty for arteriovenous shunt dysfunction. In this study, we investigated the precise radiation dose at the patients' back and at the non-targeted organs of the operators. METHODS: The radiation dose was measured with optically stimulated luminescent dosimeters and DAP on several sites including the backs of the patients, gonads, hands and lens of the operators. The studied populations were categorized into central, upper arm and forearm groups based on the lesion sites. RESULTS: The results indicated that there was a significantly higher radiation dose in the central lesion group than in the upper arm and forearm groups. Conversely, there were no specific differences in total procedure time and fluoroscopy time among groups. The radiation exposure doses in the operators showed that regardless of the site, including lens, hands and gonads of the operators, the radiation dose was significantly higher in the central lesion group. CONCLUSIONS: The closer the lesion site to the body center, the higher the radiation exposure in both the patients and operators.
BACKGROUND: Percutaneous interventions help patients with various cardiovascular diseases, however radiation exposure is a safety concern for both patients and health care providers. We previously reported that dose area product (DAP) is apparently different in central body and upper-limb areas during percutaneous transluminal angioplasty for arteriovenous shunt dysfunction. In this study, we investigated the precise radiation dose at the patients' back and at the non-targeted organs of the operators. METHODS: The radiation dose was measured with optically stimulated luminescent dosimeters and DAP on several sites including the backs of the patients, gonads, hands and lens of the operators. The studied populations were categorized into central, upper arm and forearm groups based on the lesion sites. RESULTS: The results indicated that there was a significantly higher radiation dose in the central lesion group than in the upper arm and forearm groups. Conversely, there were no specific differences in total procedure time and fluoroscopy time among groups. The radiation exposure doses in the operators showed that regardless of the site, including lens, hands and gonads of the operators, the radiation dose was significantly higher in the central lesion group. CONCLUSIONS: The closer the lesion site to the body center, the higher the radiation exposure in both the patients and operators.
Entities:
Keywords:
Arteriovenous shunt dysfunction; Central lesion; PTA; Radiation exposure
Authors: Jonathan R Sugarman; Pamela R Frederick; Diane L Frankenfield; William F Owen; William M McClellan Journal: Am J Kidney Dis Date: 2003-10 Impact factor: 8.860
Authors: Joseph M Stavas; Tony P Smith; David M DeLong; Michael J Miller; Paul V Suhocki; Glenn E Newman Journal: J Vasc Interv Radiol Date: 2006-10 Impact factor: 3.464
Authors: Eliseo Vano; R Sanchez; J M Fernandez; J J Gallego; J F Verdu; M Gonzalez de Garay; A Azpiazu; A Segarra; M T Hernandez; M Canis; F Diaz; F Moreno; J Palmero Journal: Cardiovasc Intervent Radiol Date: 2008-10-18 Impact factor: 2.740